Framingham Heart Study

Institution(s): 
Boston University
Approx. Sample Size: 
111

Project:

Disease/Phenotype: 

early-onset atrial fibrillation

PI: 
Emelia Benjamin
Omics Center(s) Phase 1: 
Broad Institute Genomics Platform
NIH Program Officer: 
Starting Phase: 
Phase 1
Phases Involved: 
1
Co-PI: 
Kathryn Lunetta
Omics Center Contact: 
Short Name: 
FHS AFGen
Type of Omics: 
WGS
RNASeq
Metabolomics
Proteomics
Methylomics
External Funding: 
TOPMed Accession #: 
Omics Center(s) Other Phase (specify): 
Broad Institute Metabolomics Platform
Broad Institute and Beth Israel Proteomics Platform
Keck MGC
Northwest Genomics Center
Specify the TOPMed Phase for the Omics Center(s) selected above: 
pilot, 4.5